Related Experiment Video
Updated: Nov 29, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Cirrhotic Cardiomyopathy-A Veiled Threat
Ecaterina Scarlatescu1, Sergey P Marchenko2, Dana R Tomescu1,3
1From the Department of Anaesthesia and Intensive Care Medicine III, Fundeni Clinical Institute, Bucharest, Romania.
Cirrhotic cardiomyopathy (CCM) is often missed in stable patients. Early cardiac assessment using advanced echocardiography is crucial for diagnosing CCM and improving outcomes in liver cirrhosis patients.
Area of Science:
- Cardiology
- Hepatology
- Medical Imaging
Background:
- Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in liver cirrhosis patients without prior heart disease.
- Current diagnostic criteria (2005) often miss early-stage CCM due to subtle symptoms.
Purpose of the Study:
- To review CCM pathophysiology, diagnostic imaging, and therapeutic options.
- To emphasize the importance of early CCM detection in cirrhotic patients.
Main Methods:
- Review of pathophysiological aspects of CCM.
- Evaluation of contemporary cardiovascular imaging techniques for CCM diagnosis.
- Summary of current therapeutic strategies.
Main Results:
- CCM diagnosis is frequently delayed, contributing to poor outcomes.
- Advanced echocardiography can detect subclinical cardiac dysfunction.
- Early diagnosis is vital for managing cirrhotic patients.
Conclusions:
- Comprehensive cardiovascular assessment is essential for cirrhotic patients.
- Newer echocardiographic methods aid in early CCM detection.
- Timely diagnosis improves patient management and prognosis.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

